GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » EPS (Basic)

Heart Test Laboratories (Heart Test Laboratories) EPS (Basic) : $-48.00 (TTM As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories EPS (Basic)?

Heart Test Laboratories's basic earnings per share (Basic EPS) for the three months ended in Jan. 2024 was $-3.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2024 was $-48.00.

Heart Test Laboratories's EPS (Diluted) for the three months ended in Jan. 2024 was $-3.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $-48.00.

Heart Test Laboratories's EPS without NRI for the three months ended in Jan. 2024 was $-3.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2024 was -48.00.

During the past 3 years, the average EPS without NRI Growth Rate was -19.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Heart Test Laboratories's highest 3-Year average EPS without NRI Growth Rate was -19.20% per year. The lowest was -19.20% per year. And the median was -19.20% per year.


Heart Test Laboratories EPS (Basic) Historical Data

The historical data trend for Heart Test Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories EPS (Basic) Chart

Heart Test Laboratories Annual Data
Trend Apr20 Apr21 Apr22 Apr23
EPS (Basic)
-47.39 -30.49 -59.52 -80.00

Heart Test Laboratories Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.00 -16.00 -13.00 -16.00 -3.00

Heart Test Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Heart Test Laboratories's Basic EPS for the fiscal year that ended in Apr. 2023 is calculated as

Basic EPS (A: Apr. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-6.354-0)/0.080
=-79.43

Heart Test Laboratories's Basic EPS for the quarter that ended in Jan. 2024 is calculated as

Basic EPS (Q: Jan. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.644-0)/0.538
=-3.06

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-48.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heart Test Laboratories  (NAS:HSCS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Heart Test Laboratories EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Heart Test Laboratories (Heart Test Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092

Heart Test Laboratories (Heart Test Laboratories) Headlines

From GuruFocus

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

By sperokesalga sperokesalga 04-17-2023